-
The president wants lawmakers to provide more funds to aid efforts to block fentanyl manufacturing and trafficking. He also says that a deal with China will require monitoring to have an impact.
-
Scholars fear that cartels will find new synthetic drugs — that may be even deadlier. Their solution: Better prevention and treatment programs.
-
The moves come one day before senior administration officials are set to visit Mexico, whose cartels are part of the global trafficking network, for meetings expected to involve discussion of the drug threat.
-
The number of different e-cig devices sold has nearly tripled despite a three-year federal effort to block kid-friendly flavors. The rise has been almost entirely driven by a wave of cheap, disposable devices imported from China.
-
The newest report angered some Republicans, who have argued the Biden administration is wrongly withholding classified information, and researchers, who accuse the U.S. of not being forthcoming.
-
Peter Ben Embarek, who led the WHO side of a joint team with scientists in China, was dismissed last year, the health agency said.
-
Health experts proposed detailed plans for a gradual end to anti-virus controls, but the government rebuffed them and dropped restrictions in December with no preparations to cope with the aftermath.
-
The House has unanimously voted to require the Director of National Intelligence to declassify information on the origins of COVID-19. It's not clear whether or not President Biden will sign the bill.
-
In the coming days, expect a strong bipartisan vote in the House on legislation pushing U.S. intelligence officials to declassify more information related to the origins of COVID.
-
The Biden administration has decided to roll back the testing requirements as cases, hospitalizations and deaths are declining in China and the U.S. has gathered better information about the surge.